The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

Glucotrack (Nasdaq:GCTK) may be bringing its continuous blood glucose monitor (CBGM) technology to automated insulin delivery ...

Glucotrack (GCTK) will participate in the FORGETDIABETES bionic pancreas initiative that will develop a long-term, automated insulin delivery ...

Continuous Blood Glucose Monitor will be integrated with automated insulin delivery system for major EU diabetes studyRUTHERFORD, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: ...

DB Biomedical Ltd, a Nigerian-founded health technology company, has launched DB GlucoTrack, a web-based application designed ...

A new agreement with OneTwo Analytics AB will allow Glucotrack to leverage next-generation artificial intelligence and machine learning-based analytics to evaluate clinical study data from its continu ...

Glucotrack, Inc. has announced the successful completion of its first human clinical study for a novel continuous glucose monitoring system. The study, which focused on safety and procedural aspects, ...

In a strategic partnership, Glucotrack has collaborated with OneTwo Analytics to enhance the evaluation of its Continuous Blood Glucose Monitor clinical study data using AI-driven analytics.

The partnership aims to enhance the evaluation of Glucotrack’s Continuous Blood Glucose Monitor (CBGM) clinical study data using advanced artificial intelligence and machine learning analytics. The ...